Multivalent Lactobionic Acid and N‐Acetylgalactosamine‐Conjugated Peptide Nucleic Acids for Efficient In Vivo Targeting of Hepatocytes
Advanced Healthcare Materials · 2023
DOI: 10.1002/adhm.202202859 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2023. Verfasst von Vikas Kumar und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT, 06269, USA. Hauptthemen laut MEDLINE: Peptide Nucleic Acids. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Peptide nucleic acids (PNAs) are used/applied in various studies to target genomic DNA and RNA to modulate gene expression. Non‐specific targeting and rapid elimination always remain a challenge for PNA‐based applications. Here, the synthesis, characterization, in vitro and in vivo study of di lactobionic acid (diLBA) and tris N‐acetyl galactosamine (tGalNAc) conjugated PNAs for liver‐targeted delivery are reported. For proof of concept, diLBA, and tGalNAc conjugated PNAs (anti‐miR‐122 PNAs) were synthesized to target microRNA‐122 (miR‐122) which is over‐expressed in the hepatic tissue. Different lengths of anti‐miR‐122 PNAs conjugated with diLBA and tGalNAc are tested. Cell culture and in vivo analyses to determine biodistribution, efficacy, and toxicity profile are performed. This work indicates that diLBA conjugates show significant retention in hepatocytes in addition to tGalNAc conjugates after in vivo delivery. Full‐length PNA conjugates show significant downregulation of miR‐122 levels and subsequent de‐repression of its downstream targets with no evidence of toxicity. The results provide a robust framework for ligand‐conjugated delivery systems for PNAs that can be explored for broader biomedical applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT, 06269, USA.
- School of Pharmacy, University of Saint Joseph, West Hartford, CT, 06117, USA.
ORCID-Profile: Raman Bahal
Förderung
- NCI NIH HHS
Zitieren
APA
Kumar, V., Wahane, A., Gupta, A., Manautou, J. E., & Bahal, R. (2023). Multivalent Lactobionic Acid and N‐Acetylgalactosamine‐Conjugated Peptide Nucleic Acids for Efficient In Vivo Targeting of Hepatocytes. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202202859
Vancouver
Kumar V, Wahane A, Gupta A, Manautou JE, Bahal R. Multivalent Lactobionic Acid and N‐Acetylgalactosamine‐Conjugated Peptide Nucleic Acids for Efficient In Vivo Targeting of Hepatocytes. Advanced Healthcare Materials. 2023. doi:10.1002/adhm.202202859
BibTeX
@article{Kumar2023,
author = {Kumar, Vikas and Wahane, Aniket and Gupta, Anisha and Manautou, José E and Bahal, Raman},
title = {Multivalent Lactobionic Acid and N‐Acetylgalactosamine‐Conjugated Peptide Nucleic Acids for Efficient In Vivo Targeting of Hepatocytes},
journal = {Advanced Healthcare Materials},
year = {2023},
doi = {10.1002/adhm.202202859}
}
EUVIMED